| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Ivanti unifies IT processes and security operations to better manage and secure the digital workplace. For more than three decades, we have built our reputation on helping IT professionals fix their security issues and optimize their user experience. Our sought-after systems are some of the best in the industry. From patch and asset management to IT service delivery and security, our software is everything you need to take your IT operations to the next level. We also ensure that supply chains and warehouse teams have the most up-to-date technology in order to perform their essential functions.
NABU is a digital reading app and mother tongue publishing platform making literacy accessible to children globally
Let’s Go. Let’s Shop. Let’s Play.
Cloaked is a company that provides consumer privacy solutions for the connected world we live in. Their product allows users to generate real working identities with a single click, call, text, and email from wherever they normally do without sharing t...